TY  - JOUR

T1  - Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy.

JO  - Cancer Chemother Pharmacol

PY  - 2010/04/01

AU  - Clyburn RD

AU  - Reid P

AU  - Evans CA

AU  - Lefley DV

AU  - Holen I

ED  - 

DO  - DOI: 10.1007/s00280-009-1106-6

VL  - 65

IS  - 5

SP  - 969

EP  - 978

Y2  - 2024/12/21

ER  -